
Human Biobanking Applications Global Trends, Estimates And Forecasts, 2014-2020 - Industry Overview
Description
Human Biobanking Applications Global Trends, Estimates And Forecasts, 2014-2020 - Industry Overview
Biobanks are large collections of biological specimens (tissue and blood samples) with individual specimen information developed under the auspices of public or private initiative for use in biomedical research. Biobanks contain large collections of DNA collected from individuals diagnosed of specific diseases accompanied by detailed health history. Researchers and clinicians investigate biospecimens of specific individuals for indications/diagnosis of disease. These specimens could be used to get DNA, proteins and other molecules that may help in understanding disease progression.
Steps to compile preserve and supply samples for experimentation and study have led to the growth of a fresh dimension in biobanking. Though to organize larger facilities the steps are evident, but huge numbers of DNA, RNA and tissue samples that are present in freezers in personal labs all across the globe is much more than the numbers in the compilations preserved in the national and organizational bio facilities. Having mentioned it would be ridden with problems to use samples collected by different individuals at different locations.
Medical and Genealogical data related to the samples stored in a Biobank are equally important, and Biobanks can be termed as both scientific and social projects. The rapid advances made in genome science of late have made it considerably easier to obtain, save and analyze genetic data.
Thus, large Biobanks can now be analyzed in greater depth, helping to enhance understanding of the biodiversity of the human race. On a large scale, it is vital that Biobanks and related issues are standardized and established across the globe, especially in developing countries.
This is an ongoing process, and there is as yet no particular set of procedures that can be called ―best‖, but there is worldwide focus on improving in this area. The ultimate objective of any Biospecimen resource is to indentify Biomarkers (measurable indicators of disease in a given sample), and this analysis must be done without bias on specimens that have not been compromised in their quality or integrity.
Current advances in genomics technology have made it possible to obtain genetic information from these collections in a faster, cheaper and easier manner for whole genome analysis. Biobanks should be used for investigating the biological biodiversity seen among human populations.
The key to developing personalized medicine and achieving translational research success is ensuring that proven methods are used to extract, store and process high-quality Bio-samples. There has been, and will be, a lot of effort to standardize methods and techniques so that Biobanks across the world can be assured of quality practices.
However, the demands made of modern Biobanks are beginning to outpace the finances available, and so the biorepositories might have to be more selective in what they store and the methods they employ to preserve their samples.
Biobanking is getting recognition a May donor samples and medical data is preserved in bio banks gaining all over the world. The unique innovations are helpful to both the government and to research facilities to analyze and keep record of the bio-sample compilation.
Biobanks are large collections of biological specimens (tissue and blood samples) with individual specimen information developed under the auspices of public or private initiative for use in biomedical research. Biobanks contain large collections of DNA collected from individuals diagnosed of specific diseases accompanied by detailed health history. Researchers and clinicians investigate biospecimens of specific individuals for indications/diagnosis of disease. These specimens could be used to get DNA, proteins and other molecules that may help in understanding disease progression.
Steps to compile preserve and supply samples for experimentation and study have led to the growth of a fresh dimension in biobanking. Though to organize larger facilities the steps are evident, but huge numbers of DNA, RNA and tissue samples that are present in freezers in personal labs all across the globe is much more than the numbers in the compilations preserved in the national and organizational bio facilities. Having mentioned it would be ridden with problems to use samples collected by different individuals at different locations.
Medical and Genealogical data related to the samples stored in a Biobank are equally important, and Biobanks can be termed as both scientific and social projects. The rapid advances made in genome science of late have made it considerably easier to obtain, save and analyze genetic data.
Thus, large Biobanks can now be analyzed in greater depth, helping to enhance understanding of the biodiversity of the human race. On a large scale, it is vital that Biobanks and related issues are standardized and established across the globe, especially in developing countries.
This is an ongoing process, and there is as yet no particular set of procedures that can be called ―best‖, but there is worldwide focus on improving in this area. The ultimate objective of any Biospecimen resource is to indentify Biomarkers (measurable indicators of disease in a given sample), and this analysis must be done without bias on specimens that have not been compromised in their quality or integrity.
Current advances in genomics technology have made it possible to obtain genetic information from these collections in a faster, cheaper and easier manner for whole genome analysis. Biobanks should be used for investigating the biological biodiversity seen among human populations.
The key to developing personalized medicine and achieving translational research success is ensuring that proven methods are used to extract, store and process high-quality Bio-samples. There has been, and will be, a lot of effort to standardize methods and techniques so that Biobanks across the world can be assured of quality practices.
However, the demands made of modern Biobanks are beginning to outpace the finances available, and so the biorepositories might have to be more selective in what they store and the methods they employ to preserve their samples.
Biobanking is getting recognition a May donor samples and medical data is preserved in bio banks gaining all over the world. The unique innovations are helpful to both the government and to research facilities to analyze and keep record of the bio-sample compilation.
Table of Contents
- III. INDUSTRY OVERVIEW
- A. BIOBANKING - GEOGRAPHICAL DISTRIBUTION IN DETAIL
- BIOBANKING IN THE AMERICAS
- CANADA
- TO ASSESS THE SCALE AND LIMITATIONS OF INDUSTRY ACCESS TO
- PUBLICLY-FINANCED BIOBANKS IN CANADA
- THE CANADIAN LONGITUDINAL STUDY ON AGING: BIOREPOSITORY FUNCTIONS AND NETWORKS
- BRAZIL
- OUTCOMES TO GIVE TO CONTRIBUTORS: A DEBATE IN BRAZIL
- USA
- STATUS ON THE DEVELOPMENT AND GROWTH OF A COMBINED SYSTEM OF REPOSITORIES
- AT THE UNIVERSITY OF IOWA
- BIOBANKING IN EUROPE
- CONSOLIDATION ON PRESENT ADVANTAGES
- EUROPEAN BIOBANKS ARE CRUCIAL RESOURCES ASSETS FOR THE DISTRIBUTION OF
- INDIVIDUALIZED MEDICINE
- COHORTS AS A POTENTIAL INSTRUMENT TO KNOW PERSONALIZED DISTINCTION
- ETHICAL, LEGAL AND SOCIAL ISSUES (ELSI)
- PRIORITY ISSUES FOR PERSONALIZED MEDICINE WITHIN EUROPE
- BIOBANKING AND BIOMOLECULAR RESOURCES INVESTIGATE COMMUNICATIONS
- - EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM
- FUTURE ENTRY IN TO BIGGER EUROPEAN COHORTS VIA TRANSNATIONAL
- BIOBANKING INFRASTRUCTURE BBMRI-LPC
- 9 YEARS RELATING SWISS BIOBANKS – EN ROUTE TO A SWISS BIOBANKING POLICY
- GERMANY
- CONSTANT AND MAINTAINANCE AND SUPPORT OF BIOBANK-BASED MEDICAL RESEARCH:
- A DECADE OF EXPERIENCE IN GERMANY
- AUSTRIA
- UNITED KINGDOM
- COMBINED EFFECTIVE NETWORK OF BIOBANKS
- 153. CCB INVENTION OF METHODS FOR DATA SOURCING OF BIOLOGICAL SAMPLES
- TO ALL TYPES OF BIOBANKS
- 154. CCB INVENTION TO BIOBANKS FOR MAINTAINING MINIMUM STANDARDS
- 155. CCB INVENTION TO BIOBANKS FOR BEST PRACTICE STANDARDS
- ITALY
- BIOBANKS AND ETHICAL CONCERNS IN ITALY
- OTHER EUROPEAN COUNTRIES
- STRATEGY DEVELOPMENT FOR EMERGING BIOBANKS ON THE EXAMPLE OF KOSOVO AND ALBANIA
- BIOBANKING IN ASIA-PACIFIC
- JAPAN
- EVALUATION OF ID INTEGRITY WITH ABO BLOOD TYPING-QUESTIONNAIRE TO GENOMIC
- DATA IN JAPANESE BIOBANK
- ASSESSMENT OF CELL-TYPE COMPOSITION IN PERIPHERAL BLOOD MONONUCLEAR
- CELLS ENHANCES VALUE OF OMICS DATA IN BIOBANK RESEARCH
- SOUTH KOREA
- CURRENT TRENDS IN KOREA GYNECOLOGIC CANCER BANK
- EBIOBANKING SYSTEM FOR KOREA GYNECOLOGIC CANCER BANK
- CHINA
- ACHIEVEMENTS
- BIOBANKING FOR THE BORN IN GUANGZHOU COHORT STUDY: AN INNOVATIVE RESOURCE
- FOR MATERNAL AND CHILD HEALTH RESEARCH IN CHINA
- AIMS
- ADVANTAGES
- CONSTRUCTION OF SHANGHAI CANCER BIOBANK STAGE FOR RESEARCH
- INDIA
- OBJECTIVES
- GOALS
- AREAS
- PRINCIPLES
- THE AGE BIO-BANKING IN INDIA
- TO CREATE A DISEASE-LINKED RELIABLE BIOBANK IN INDIA
- MORAL CONCERNS IN BIOBANKING: STEPPING UP THE PROGRAM IN INDIA
- BIOBANKING IS A PROMISING PROPOSITION IN INDIA-FACTORS
- I. ETHICAL CONCERNS WITH REGARD TO BIOBANKING
- PEOPLE‟S PERSPECTIVE TOWARDS BIOBANKING RESEARCH
- ACCEPTANCE BY CONTRIBUTORS IN BIOBANKING RESEARCH
- CONSENT TYPES
- REMOVAL OF CONSENT/OBLITERATION OF BIO-SAMPLES
- CHIEF CAUSES FOR PULL OUT
- PRIVACY AND SECRECY
- 156. METHODS TO LINK / DELINK DATA / SAMPLES WITH THEIR IDENTIFIERS
- II. ETHICAL ISSUES LINKED TO RESEARCH PROCEDURES
- STORAGE OF SAMPLES
- DERIVED OR EXTENSIVE USES OF STORED SAMPLES
- RELOCATION OF SAMPLES AND INFORMATION
- III. CONCLUSION
- FIRST BIOBANK BY 2016 IN EASTERN INDIA
- AUSTRALIA
- AUSTRALIAN PROSTATE CANCER BIO-RESOURCE, 2015
- ENHANCING BIO-SAMPLES QUALITY INSIDE THE BANKING SYSTEM: AN AUSTRALIAN OUTLOOK
- BIOBANKING IN REST OF WORLD
- THE CONSEQUENCES OF MINI-BIOBANK IN HAZARDOUS CLIMATES IN IRAQ
- BIODIVERSITY/ENVIRONMENTAL MICROBIAL STOREHOUSE SYSTEM IN EMERGING
- NATIONS-SPOTLIGHT ON NIGERIA
- THE PROGRESS OF THE NATIONAL BIOBANKING INDUSTRY FOR PRESERVATION
- OF SOUTH AFRICAN BIODIVERSITY
- QATAR BIOBANK: PUBLIC HEALTH CONCERNS REPORTED
- BIOBANKING INITIATIVE IN SAUDI ARABIA: THE CEGMR BIOBANK KNOW-HOW
- B. A REVIEW ON BIO “BANKS”
- RELEVANCE OF BIOBANKS IN SCIENTIFIC RESEARCH
- C. MAJOR PROSPECTS FOR BIOREPOSITORIES IN THE FUTURE
- THE KEY IMPACT OF BIOREPOSITORIES IN ITS APPLICATIONS
- BIGGEST CHALLENGES AND OPPORTUNITIES IN BIOREPOSITORIES
- BIOBANKS WILL BE CHALLENGED BY INCREASING FINANCIAL PRESSURES
- BIGGEST OPPORTUNITIES
- PRESENT CHALLENGES OF BIOBANKING: BIOETHICAL AND PROPERTY ISSUES
- ADDED VALUE OF BIOBANKS FOR HEALTH: AN EVOLUTIONARY PERSPECTIVE
- FUTURE CHALLENGES
- CONCLUSIONS
- D. INDUSTRY ACTIVITIES
- MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/
- INNOVATIONS/PRODUCT LAUNCHES/ETC……
- CESCA THERAPEUTICS ENTERS INTO COLLABORATIVE AGREEMENT WITH CENTER FOR
- IMMUNE CELL THERAPIES AT MEMORIAL SLOAN KETTERING CANCER CENTER
- AGILENT TECHNOLOGIES TO ACQUIRE SEAHORSE BIOSCIENCE, INDUSTRY LEADER IN
- TOOLS FOR MEASURING CELL METABOLISM
- INTERNATIONAL STEM CELL CORPORATION ANNOUNCES NEXT PHASE OF RESEARCH
- COLLABORATION WITH ROHTO PHARMACEUTICAL CO., LTD. OF JAPAN
- PARTNERS GET $12.3M TO ADVANCE GENOMIC MEDICINE
- NEW STUDY DEMONSTRATES ABSENCE OF EXTRACTABLE ORGANIC CONTAMINANTS
- IN MICRONIC‟S POLYPROPYLENE SAMPLE STORAGE TUBES
- VALEANT PHARMACEUTICALS TO ACQUIRE SYNERGETICS USA
- SYSMEX RECEIVES IN-VITRO DIAGNOSTIC APPROVAL FOR MANUFACTURING AND SALES
- OF THREE PLATELET AGGREGATION AGONIST REAGENT KITS
- AMAG PHARMACEUTICALS COMPLETES ACQUISITION OF CORD BLOOD REGISTRY
- BIOTEK SYNERGY™ NEO2 GRANTED CISBIO HTRF® CERTIFICATION
- AVITA MEDICAL ANNOUNCES NEW RESEARCH PARTNERSHIP WITH UNIVERSITY OF HUDDERSFIELD
- STEMCELL TECHNOLOGIES INC. ENTERS A LICENSING AGREEMENT WITH
- IPS ACADEMIA JAPAN, INC. FOR INDUCED PLURIPOTENT STEM CELL RESEARCH TECHNOLOGIES
- IMMATICS AND MD ANDERSON ANNOUNCE LAUNCH OF IMMATICS US, INC.,
- TO DEVELOP MULTIPLE T-CELL AND TCR-BASED ADOPTIVE CELLULAR THERAPIES
- BIO-RAD INTRODUCES THE IH-500, A FULLY AUTOMATED RANDOM ACCESS SYSTEM
- FOR BLOOD TYPING AND SCREENING
- GROUNDBREAKING CLINICAL TRIAL TO ASSESS USE OF NEWBORN STEM CELLS
- IN THE TREATMENT OF PEDIATRIC STROKE
- GENOTYPING BEGINS ON NIDA‟S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX,
- BIOREALM AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
- STEM CELLS - PROMISING OPTIONS FOR ALTERNATIVE MEDICAL THERAPEUTIC APPROACHES
- CELGENE HANDED $1 BILLION TO SMALL BIOTECH DEVELOPER JUNO THERAPEUTICS
- MEDIMMUNE PARTNERS WITH THE UNIVERSITY OF SHEFFIELD TO GENERATE INNOVATIONS
- IN CELL FACTORY ENGINEERING SCIENCE
- CYTOX AND AFFYMETRIX FORM STRATEGIC PARTNERSHIP TO DEVELOP AND COMMERCIALIZE
- BLOOD-BASED GENETIC ASSAY FOR ALZHEIMER‟S DISEASE RISK ASSESSMENT
- GENOTYPING BEGINS ON NIDA‟S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX,
- BIOREALM, AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
- MOUNT SINAI MEDICAL CENTER SELECTS STEMSOFT CLINIC
- INTEGRA LIFESCIENCES COMPLETES ACQUISITION OF TEI BIOSCIENCES AND TEI MEDICAL
- BLOODCENTER LAUNCHES GENE DELETION/DUPLICATION ANALYSIS
- CRYOPORT PROVIDES CRYOGENIC LOGISTICS SOLUTIONS TO HEMACARE CORPORATION
- BIOMATRICA, INC. ANNOUNCES RELEASE OF DNAGARD® SALIVA HT, SALIVA DNA COLLECTION
- SERACARE LIFE SCIENCES ANNOUNCES STRATEGIC PARTNERSHIP WITH VIVEBIO TO ENABLE
- LAKE SHORE EXHIBITING CRYOGENIC MONITORING AND CONTROL SOLUTIONS AT CEC/ICMC
- CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOGLUE® IN JAPAN
- DNA GENOTEK INC. RECEIVES CE-IVD MARK FOR ITS OMNIGENE®•GUT MICROBIOME COLLECTION KIT
- DEBIOPHARM INTERNATIONAL SA ACQUIRES FIBROTRAP SAMPLE PROCESSING
- TECHNOLOGY FROM SPINOMIX
- SYSMEX AND LABCORP ANNOUNCE A STRATEGIC COLLABORATION FOR BLOOD-BASED
- MOLECULAR TESTING SERVICES AND PRODUCTS TO SUPPORT THE DEVELOPMENT
- OF PRECISION MEDICINE IN ONCOLOGY
- RENEURON GROUP PLC S RESEARCH COLLABORATION WITH BENITEC BIOPHARMA
- STEMCELL TECHNOLOGIES LAUNCHES INNOVATIVE PRODUCTS TO SUPPORT CAR T CELL RESEARCH
- ULTRA LOW BINDING TUBES FOR PROTEOMICS
- TAKARA BIO EUROPE RELEASES AN INNOVATIVE IPS CELL CULTURE MEDIUM
- FOR PRE-CLINICAL USE: CELLARTIS® DEF-CS™ XENO-FREE CULTURE MEDIUM
- CALADRIUS BIOSCIENCES, INC. FINALIZES CORPORATE NAME CHANGE FROM NEOSTEM, INC.
- STEMGENT, A REPROCELL GROUP COMPANY LAUNCHES A NEW HIGH PERFORMANCE
- SELF-REPLICATIVE RNA REPROGRAMMING KIT
- TAKARA BIO EUROPE RELEASES AN INNOVATIVE IPS CELL CULTURE MEDIUM FOR
- PRE-CLINICAL USE: CELLARTIS® DEF-CS™ XENO-FREE CULTURE MEDIUM GÖTEBORG, SWEDEN
- OCTANE AND LONZA ANNOUNCE EXCLUSIVE COLLABORATION TO EVALUATE GROUNDBREAKING
- AUTOLOGOUS CELL THERAPY TECHNOLOGY
- AXT TO DISTRIBUTE OPENSPECIMEN BIOBANKING SOFTWARE SOLUTION
- NIKON AND LONZA FORM COLLABORATION FOR CELL AND GENE THERAPY MANUFACTURING IN JAPAN
- DNA GENOTEK INC. LAUNCHES MICROBIAL DNA SELF-COLLECTION KIT-OMNIGENE®•GUT PRODUCT
- OPTIMIZES SAMPLES FOR MICROBIOME ANALYSIS
- BIOCISION AND BROOKS AUTOMATION ANNOUNCE INDUSTRY'S FIRST PORTABLE CRYOGENIC
- BIOSPECIMEN TRANSPORT SYSTEM WITH INTEGRATED REAL-TIME TEMPERATURE MONITORING
- CRYO-CELL‟S NEW CORD BLOOD PROCESSING METHOD ENABLES PARENTS TO OBTAIN
- BETTER CORD BLOOD UNITS FOR THEIR BABIES
- AVITA MEDICAL ANNOUNCES ISSUANCE OF A NEW U.S. PATENT FOR RECELL®
- TITIAN SOFTWARE EXPANDS OFFERING WITH NEW MOSAIC FREEZER MANAGEMENT
- ALLIQUA BIOMEDICAL ANNOUNCES EXPANSION TO ITS EXCLUSIVE LICENSING AGREEMENT
- WITH CELGENE CELLULAR THERAPEUTICS
- SECURE AUTOMATED CRYOGENIC STORAGE
- LONZA, THE WORLD‟S LEADING DEVELOPER AND MANUFACTURER OF CELLS FOR REGENERATIVE
- MEDICINE THERAPEUTICS, AND NIKON CORPORATION ANNOUNCED TODAY AN EXCLUSIVE
- COLLABORATION IN THE FIELD OF CELL AND GENE THERAPY MANUFACTURING IN JAPAN.
- NEOSTEM ANNOUNCES EXPANDED CELL THERAPY MANUFACTURING RELATIONSHIP WITH KITE PHARMA
- COMBIMATRIX LAUNCHES BUCCAL SWAB DNA COLLECTION AS ALTERNATIVE TO BLOOD DRAWS
- FOR POSTNATAL GENETIC TESTING
- NEW ULTRA-LOW TEMPERATURE FREEZER OFFERS OUTSTANDING SUSTAINABILITY
- AND SAMPLE PROTECTION
- NEOSTEM, INC AND ALLCELLS, LLC TO COLLABORATE WITH MOUNT SINAI AS PART
- OF $8.8 MILLION GRANT TO FURTHER STEM CELL RESEARCH
- SYSMEX INOSTICS ANNOUNCES AGREEMENT WITH INDIVUTEST TO OFFER BLOOD BASED
- MUTATION TESTING
- CELGENE TO ACQUIRE QUANTICEL PHARMACEUTICALS
- CORD BLOOD REGISTRY® USES BIOLIFE SOLUTIONS CRYOSTOR® CLINICAL GRADE FREEZE MEDIA
- IN THE STORAGE OF UMBILICAL CORD TISSUE STEM CELLS
- FLORIDA HOSPITAL CANCER INSTITUTE SELECTS STEMSOFT CLINIC
- GENMAB ACHIEVES USD 10 MILLION MILESTONES IN DARATUMUMAB COLLABORATION WITH JANSSEN
- ALVETEX® 3D CELL CULTURE PLATFORM REACHES NEW HEIGHTS WITH
- PROJECT ABOARD THE INTERNATIONAL SPACE STATION (ISS).
- LONZA INTRODUCES CYTOSMART™ SYSTEM FOR WALK-AWAY LIVE CELL IMAGING
- BROOKS AUTOMATION INTRODUCES BIOSTORE III CRYO AUTOMATED
- CRYOGENIC SAMPLE MANAGEMENT SYSTEM
- BIOCISION AND BROOKS JOINT DEVELOPMENT PARTNERSHIP TO UNVEIL
- NEW CRYOGENIC SAMPLE HANDLING AND TRANSPORT PRODUCT
- PAML AND BLOODWORKS NW SIGN LETTER OF INTENT TO COLLABORATE ON INNOVATION
- BROOKS AUTOMATION INTRODUCES BIOSTORE III CRYO AUTOMATED
- CRYOGENIC SAMPLE MANAGEMENT SYSTEM
- BIOTIME‟S CLINICAL GRADE STEM CELLS FROM SUBSIDIARY ES CELL INTERNATIONAL TO BE
- USED IN PLANNED CIRM-FUNDED PRECLINICAL STUDIES OF HUNTINGTON‟S DISEASE
- BIOTIME LICENSES BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE TO MANUFACTURE
- CLINICAL GRADE STEM CELLS
- BLOOD CENTER AFFILIATION UNVEILS NEW NAME, EXPANDED OFFERINGS TO HEALTHCARE SYSTEMS
- LONZA INTRODUCES CYTOSMART™ SYSTEM FOR WALK-AWAY LIVE CELL IMAGING
- FUJIFILM HOLDINGS TO ACQUIRE CELLULAR DYNAMICS INTERNATIONAL, INC.
- GENVEC AND THERABIOLOGICS FORM COLLABORATION TO DEVELOP NEURAL STEM CELL MEDIATED
- CANCER THERAPIES
- CRYO-CELL INTERNATIONAL, INC., CORD BLOOD BANKING LEADER, TAKES SIGNIFICANT OWNERSHIP
- STAKE IN CORD BLOOD AMERICA, INC., AND ENCOURAGES CBAI SHAREHOLDERS
- TO VOTE AGAINST UPCOMING SHARE AUTHORIZATION PROPOSAL
- COMBIMATRIX SELECTS CRYOPORT AS LOGISTICS PARTNER FOR THE DISTRIBUTION
- OF ITS NEW GENETIC SCREENING SERVICE
- BLUECHIIP TRACKING SOLUTIONS EXECUTING STRATEGIC PRIORITIES IN BIOBANKING
- CORDLIFE PARTNERS WITH LEADING NEUROLOGIST ON STUDY IN CHILD AUTISM USING
- OWN CORD BLOOD STEM CELLS
- LEICA EM CRYO CLEM FEATURES THE WORLD‟S FIRST CRYO CLEM OBJECTIVE
- PARTNERSHIP WITH LIVE CELL IMAGING COMPANY
- ASTRAZENECA TO COLLABORATE WITH THE HARVARD STEM CELL INSTITUTE IN DIABETES
- HANDHELD WIRELESS 1D / 2D CODE READER
- BIOLIFE SOLUTIONS CRYOSTOR® CELL FREEZE MEDIA USED IN MAYO CLINIC SAFETY AND FEASIBILITY
- STUDY OF UMBILICAL CORD BLOOD-DERIVED CELLS FOR PEDIATRIC CARDIAC REGENERATION
- EXPIRATION OF THE OPTION OF TEVA UNDER THE LICENSE AGREEMENT WITH CELLCURE
- NEUROSCIENCES
- UNIVERSITY OF ILLINOIS AT CHICAGO SELECTS STEMSOFT CLINIC
- ESPERITE PIONEERS FIRST TREATMENT WORLDWIDE OF CEREBRAL PALSY USING TWO TYPES
- OF STEM CELLS
- GREINER BIO-ONE PRESENTS INNOVATIVE CRYO‟S BIOBANKING TUBES
- ESI BIO – A DIVISION OF BIOTIME, INC., ANNOUNCES ALLIANCE AGREEMENT WITH PIVOTAL
- SCIENTIFIC LTD FOR DISTRIBUTION OF STEM CELL PRODUCTS
- PUGET SOUND BLOOD CENTER IS NOW BLOODWORKS NORTHWEST
- LABCORP COMPLETES ACQUISITION OF COVANCE
- BIOLIFE SOLUTIONS LAUNCHES NEW CELL THAWING MEDIA PRODUCTS IN RESPONSE
- TO WORLDWIDE SHORTAGE OF DEXTRAN SOLUTIONS
- TIGENIX AND LONZA SIGN AGREEMENT FOR THE MANUFACTURE OF STEM CELL-BASED TREATMENT
- OF COMPLEX PERIANAL FISTULAS IN CROHN‟S DISEASE
- EPISTEM ANNOUNCES THE SUCCESSFUL EVALUATION OF NEW RNA-AMP™
- (RNA-AMPLIFICATION) TECHNOLOGY
- STEMGENT, A REPROCELL GROUP COMPANY AND TRANSPOSAGEN BIOPHARMACEUTICALS ENTER
- INTO A SERVICE PARTNERSHIP AGREEMENT PROVIDING GENETICALLY ENGINEERED STEM CELLS
- TIGENIX AND LONZA SIGN AGREEMENT FOR THE MANUFACTURE OF STEM CELL-BASED TREATMENT
- OF COMPLEX PERIANAL FISTULAS IN CROHN‟S DISEASE
- INTERNATIONAL STEM CELL CORPORATION ANNOUNCES COMPLETION OF CELL BANK FOR PARKINSON'S
- DISEASE CLINICAL TRIAL
- CELLULAR DYNAMICS MANUFACTURES CGMP HLA “SUPERDONOR” STEM CELL LINES TO ENABLE
- CELL THERAPY WITH GENETIC MATCHING
- VITRO BIOPHARMA ANNOUNCES ADVANCES IN CLINICAL APPLICATION OF STEM CELL THERAPY
- FOR NEUROLOGICAL CONDITIONS
- NEW HEALTHY AGEING BIOBANK MILESTONE
- ALLIQUA BIOMEDICAL, INC. TO ACQUIRE CELLERATION, INC.
- AGILENT TECHNOLOGIES INTRODUCES ONESEQ TO STREAMLINE CYTOGENETIC RESEARCH
- CANCERCARE MANITOBA SELECTS STEMSOFT LAB
- ALLIQUA BIOMEDICAL ANNOUNCES GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
- VALEANT AND ASTRAZENECA TO PARTNER ON BRODALUMAB
- HARVARD BIOSCIENCE ACQUIRES ALL OPERATIONS OF HEKA ELECTRONIK
- BROOKS AUTOMATION ANNOUNCES COLLABORATION AGREEMENT WITH CHART INDUSTRIES
- AVITA MEDICAL ANNOUNCES FIRST PATIENT ENROLLMENT IN US PIVOTAL STUDY OF RECELL®
- FOR THE TREATMENT OF BURNS
- NEOSTEM RECEIVES DRUG MANUFACTURE LICENSE FOR IRVINE FACILITY
- NEOSTEM AND INVETECH ANNOUNCE AGREEMENT TO DEVELOP CLOSED PROCESSING SYSTEM
- FOR CELL THERAPY MANUFACTURING
- CORD BLOOD REGISTRY AND CELLULAR DYNAMICS INTERNATIONAL ANNOUNCE COLLABORATION
- TO REPROGRAM NEWBORN STEM CELLS INTO INDUCED PLURIPOTENT STEM CELLS
- CORD BLOOD REGISTRY AND CHINA CORD BLOOD CORPORATION ENTER INTO STRATEGIC COLLABORATION
- LIFECELL CORPORATION AND NOVADAQ TECHNOLOGIES AGREE TO EARLY TRANSITION OF SPY ELITE® INTRAOPERATIVEPERFUSION ASSESSMENT SYSTEM BUSINESS BACK TO NOVADAQ.
- FDA CLEARS MAYO CLINIC FOR MANUFACTURE OF NUROWN AND PARTICIPATION IN BRAINSTORM‟S PHASE 2 ALS TRIAL
- BEAUMONT, BOTSFORD, OAKWOOD REACH DEFINITIVE AGREEMENT TO CREATE NEW, NOT-FOR-PROFIT HEALTH ORGANIZATION
- THERMO FISHER SCIENTIFIC COMPLETES ACQUISITION OF LIFE TECHNOLOGIES CORPORATION
- BIOPTA ANNOUNCES LAUNCH OF INDUSTRY‟S FIRST CATALOGUE OF IN VITRO HUMAN TISSUE ASSAYS
- THERMO FISHER SCIENTIFIC REACHES AGREEMENT TO SELL ITS CELL CULTURE,
- GENE MODULATION AND MAGNETIC BEADS BUSINESSES TO GE HEALTHCARE
- BIOMATRICA AND SIGMA-ALDRICH SIGN DISTRIBUTION AGREEMENT
- ATHERSYS ANNOUNCES NEW PATENTS IN JAPAN FOR STEM CELL AND REGENERATIVE
- MEDICINE TECHNOLOGY
- CELL THERAPY'S HEART TISSUE REGENERATION HOPE
- CELLULAR DYNAMICS SIGNS AGREEMENT WITH NESTLE INSTITUTE OF HEALTH SCIENCES
- TO SUPPLY ICELL® AND MYCELL® PRODUCTS FOR NUTRITIONAL RESEARCH
- LIFECELL CORPORATION ACQUIRES ADVANCED ADIPOSE TISSUE INJECTOR
- COMBIMATRIX ANNOUNCES CONTRACT WITH GALAXY HEALTH NETWORK
- COMBIMATRIX ANNOUNCES PARTNERSHIP WITH PROPATH TO PROVIDE
- PRODUCTS OF CONCEPTION TESTING
- STEMSOFT SOFTWARE INC. AND JAF CONSULTING, INC. ANNOUNCE COLLABORATIVE PARTNERSHIP
- THERMO FISHER SCIENTIFIC REACHES AGREEMENT TO SELL ITS CELL CULTURE,
- GENE MODULATION AND MAGNETIC BEADS BUSINESSES TO GE HEALTHCARE
- NEW DMSO-RESISTANT 1536 WELL STORAGE PLATE
- BMG LABTECH AND INVIVOSCIENCES, INC. INITIATE MARKET COLLABORATION TO
- ACCELERATE DRUG DISCOVERY IN ENGINEERED 3D TISSUES
- LOW PROFILE SCREW CAPS DESIGNED IN CONJUNCTION WITH THE HANNOVER
- UNIFIED BIOBANK LAUNCHED BY MICRONIC
- QUEENSLAND NODE OF APCB GAIN ACCESS TO UNIQUE SAMPLES
- THERMO FISHER SCIENTIFIC BRINGS SEVERAL INNOVATIONS IN BIOPROCESSING
- TECHNOLOGIES AND SYSTEMS
- E. MARKET TRENDS
- GROUNDBREAKING TECHNOLOGY COLLABORATION TO OPTIMIZE MEDICAL RESEARCH
- FIRST 300 CELL LINES TO SUPPORT AUTISM, HEART, LIVER, LUNG AND EYE DISEASE RESEARCH
- TOWARDS „ENGAGEMENT 2.0‟: INSIGHTS FROM A STUDY OF DYNAMIC CONSENT
- WITH BIOBANK PARTICIPANTS
- FINDING BIOMARKERS FOR EARLY LUNG CANCER DIAGNOSIS
- BIOBANKING VIABLE IMMUNE CELLS - TRANSPORTATION MATTERS!
- CANCER BIOBANK INFORMS FUTURE TREATMENT
- WORLD‟S FIRST T CELL-QUALIFIED SERUM REPLACEMENT NOW AVAILABLE
- BIOBANKING: A VITAL ASSET FOR BELGIUM SCIENTIFIC EXCELLENCE
- PLASMA BIOBANKING: MAXIMIZING PATIENT SAMPLES
- BRIDGING „BIOBANKING‟ AND BIOMEDICAL RESEARCH ACROSS EUROPE AND AFRICA:
- „B3AFRICA‟ LAUNCHED IN CAPE TOWN
- FINDING THE BEST WAY TO PROCESS GUT MICROBIOME SAMPLES
- INNOVATION IN BIOBANKING: PUSHING THE BOUNDARIES
- NEW RESEARCH TOOL TRACKS REAL-TIME DNA-PROTEIN BINDING IN CELLS
- SEOULIN BIOSCIENCE TO DISTRIBUTE CELLULAR DYNAMICS‟ PRODUCTS IN KOREA
- CRYOGENIC STORAGE SOLUTION AVAILABLE IN EUROPE
- A NEXT-GEN BIOBANK THAT‟S BASED ON THE CLOUD
- HEALTH RESEARCH GROUP MAKES RECOMMENDATIONS ON EU DATA PROTECTION REFORMS
- GENOTYPING BEGINS ON NIDA‟S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX, BIOREALM,
- AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
- REG-GALAPAGOS LICENSES ORGANOID TECHNOLOGY FROM THE HUB FOUNDATION FOR
- USE IN CYSTIC FIBROSIS AND IBD RESEARCH
- CCFA LAUNCHES DEVELOPMENT OF WORLD‟S LARGEST RESEARCH DATABASE FOR CROHN‟S
- DISEASE AND ULCERATIVE COLITIS
- THE JOINT VENTURE OF SYNOVIAL TISSUE CRYOPRESERVATION
- ANTIFREEZE POLYMER PROTECTS CELLS AS THEY THAW
- AUSTRALIA‟S FIRST COMPREHENSIVE SKIN CANCER TISSUE BANK
- AWARENESS OF THE PROCURE BIOBANK
- BIOSAMPLES AND CRYOPRESERVATION: WHAT TUBE SHOULD I USE?
- IBBL TEACHES THE INS AND OUTS OF BIOBANKING
- NHLBI NEXT GEN CONSORTIUM PARTNERS WITH WICELL TO DISTRIBUTE OVER
- 1,500 WELL-CHARACTERIZED, NOVEL CELL LINES FOR USE IN DISEASE RESEARCH
- AUTOMATED PBMC ISOLATION FOR BIOBANKING WITH TECAN‟S FREEDOM EVO®
- BIOTEK EXPANDS IN THE UNITED KINGDOM
- ECACC AND DS PHARMA – 10 YEARS SUPPORTING CELL CULTURE SCIENCE IN JAPAN
- DRIED BLOOD SPOTS: NEW APPLICATIONS FOR BIOBANKING?
- MULTICARE, BLOODWORKS NW EXPAND SOUTH SOUND CORD BLOOD COLLECTION
- NEW ULTRA-LOW TEMPERATURE FREEZER OFFERS OUTSTANDING SUSTAINABILITY
- AND SAMPLE PROTECTION
- BIOBANKING FOR GLOBAL PROSTATE CANCER RESEARCH COLLABORATION
- THE UK HAS JOINED THE BIOBANKING AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE
- - EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM (BBMR-ERIC) AT ITS GENERAL ASSEMBLY
- BIOBANKING COLLABORATION FOR LUNG CANCER RESEARCH
- LONG-TERM BIOBANKING: HOW LONG CAN YOU HOLD SAMPLES?
- CONTROLLING SAMPLE EXPOSURE TO TEMPERATURE VARIABILITY
- THL OBTAINED PERMISSION TO TRANSFER OLD SAMPLE COLLECTIONS TO THL BIOBANK
- CHOOSING COLLECTION KITS VERSUS BULK SUPPLIES
- FUTURE OF BIOBANKING AND TRANSLATIONAL RESEARCH IN CHINA
- UW TO SELL PATIENT TISSUE SAMPLES TO SUPPORT RESEARCH
- MSC FROM CORD TISSUE USED TO TREAT GRAFT-VERSUS-HOST DISEASE
- FIRST PATIENT SUCCESSFULLY TRANSPLANTED WITH CRYOPRESERVED (FROZEN) NICORD®
- IN GAMIDA CELL‟S ONGOING PHASE I/II CLINICAL TRIAL FOR BLOOD CANCERS
- STORE FOR 20 MILLION BIO-SAMPLES OPENS IN MILTON KEYNES
- PASS THE TISSUE: UA CREATES BIO REPOSITORY TO SHARE WITH COMPETING UNIVERSITIES
- COLD STORAGE: DEEP-FREEZE UNIT IS VITAL TO OKLAHOMA MEDICAL RESEARCH FOUNDATION'S WORK
- NEW EUROPEAN STORAGE BANK FOR STEM CELL STUDIES COMING TO BABRAHAM RESEARCH CAMPUS
- STEM CELLS: FIRST THERAPY APPROVED BY EU
- NATIONAL BIOBANK SYMPOSIUM STRENGTHENS COOPERATION IN THE BIOBANK RESEARCH
- FROM DRIED COD TO TISSUE SAMPLE PRESERVATION
- HEMATOLOGIC CANCERS: UMBILICAL CORD TRANSPLANTATION
- NEW METHOD TO MULTIPLY STEM CELLS MAKES CORD BLOOD EVEN MORE VALUABLE
- BIOHEART ANNOUNCES PARTNERSHIP IN COLOMBIA
- SURVEY OF BIOBANKS 2014 IN AUSTRALIA
- BIOBANKS COOPERATION WILL BRING OPPORTUNITIES TO THE INDIVIDUAL TREATMENT
- OF PATIENTS PUBLISHED
- LUXEMBOURG‟S BIOBANK COLLABORATES WITH US NATIONAL CANCER INSTITUTE
- IBBL IS CENTRAL BIOBANK FOR A NEW EUROPEAN CANCER RESEARCH PROGRAMME
- CORD BLOOD CURE FOR AUTISM
- RESEARCH THAT EXPLORES THE USE OF UMBILICAL CORD BLOOD CELLS
- NEW DISTRIBUTION PARTNER FOR BIOTISSUE IN GERMANY, AUSTRIA AND SWITZERLAND
- RESEARCH THAT EXPLORES THE USE OF UMBILICAL CORD BLOOD CELLS
- TWO NEW CHORDOMA CELL LINES DEVELOPED, HEADING TO REPOSITORY
- VALLEY MEDICAL CENTER AND PSBC PARTNER IN CORD BLOOD PROGRAM
- COULD PREMATURE BABIES BENEFIT FROM THEIR OWN CORD BLOOD STEM CELLS
- NCI BIOBANK SURVEY
- THL BIOBANK IN FINLAND RECEIVES LICENSE TO OPERATE
- FAMILYCORD INTRODUCES FAMILYCORD VENEZUELA
- PLASTICELL SIGNS DEAL WITH JCR PHARMACEUTICALS TO USE COMBICULT ®
- STEM CELL TECHNOLOGY IN JAPAN
- EBISC – THE FIRST EUROPEAN BANK FOR INDUCED PLURIPOTENT STEM CELLS
- SUCCESSFUL RELEASE OF SAMPLE TO TREAT SCID
- WICELL EXPANDS OFFERINGS FOR RESEARCHING HUMAN DISEASE WITH CELL LINES DESIGNED BY LIFE
- TECHNOLOGIES FOR FLUORESCENT PROTEIN EXPRESSION
- BIOBANKING FROM THE PATIENT PERSPECTIVE
- THE FUTURE OF BIOBANKING
- THE CHALLENGE: RECRUIT 500,000 PARTICIPANTS
- 2015 EU DATA PROTECTION REGULATION – IMPACT ON RESEARCH UPDATES
- LATEST CRYO-CELL INTERNATIONAL DEVELOPMENTS
- CORD BLOOD STEM CELLS CAN TREAT OVER 80 LIFE-THREATENING DISEASES
- ENRICHING DATASETS THROUGH NORWEGIAN BIOBANK DATA FROM LIFANDIS AS AND
- THE IMS PYGARGUS METHODOLOGY
- IRVINE SCIENTIFIC INTRODUCES DMSO-FREE, CHEMICALLY-DEFINED CRYOPRESERVATION
- SOLUTION FOR MESENCHYMAL STEM CELLS
- 157. WORLDWIDE KEY PLAYERS INTO HUMAN BIOBANKING INDUSTRY THAT PROJECT
- IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
- F. KEY COMPANY PROFILES
- NORTH AMERICA
- VERICEL CORPORATION
- ACORDA THERAPEUTICS, INC.
- ALPHA CORD, INC.
- AFFYMETRIX, INC.
- CELLERANT THERAPEUTICS, INC.
- CRYO-CELL INTERNATIONAL, INC.
- MESOBLAST, INC.
- ATGC LABS
- AUTOGEN, INC.
- BARBER NICHOLS
- BECKMAN COULTER, INC.
- BIOCISION
- U.S. STEM CELL, INC.
- BIOLIFE SOLUTIONS, INC.
- BIOLOGICAL SPECIMEN INVENTORY SYSTEM
- BIOMATRICA, INC.
- BIOSTORAGE, LLC
- CTI BIOPHARMA CORP.
- CHART INDUSTRIES, INC.
- CHARTER MEDICAL, LTD.
- CORCELL, INC.
- CORD BLOOD REGISTRY
- CORE DYNAMICS (USA), INC.
- CRYOLIFE, INC.
- CRYOMAGNETICS, INC.
- CRYOPLUS, INC.
- CRYOXTRACT
- CUSTOM BIOGENIC SYSTEMS
- DATAWORKS DEVELOPMENT, INC.
- DNA GENOTEK, INC.
- EPL ARCHIEVES, INC.
- GENZYME CORP.
- GILEAD SCIENCES, INC.
- HAMILTON STORAGE TECHNOLOGIES
- LABVANTAGE SOLUTIONS, INC
- LABWARE, INC.
- LIFENET HEALTH
- CALADRIUS BIOSCIENCES, INC.
- EPPENDORF, INC.
- NOVARE BIOLOGISTICS
- ORIGEN BIOMEDICAL, INC.
- OSIRIS THERAPEUTICS, INC.
- PACIFIC BIO-MATERIAL MANAGEMENT, INC.
- PROMEDDX, LLC
- PROVIA LABORATORIES, LLC
- QIAGEN NV
- RAND CORPORATION
- RURO
- SERACARE LIFE SCIENCES
- SCIENTIFIC INSTRUMENTS, INC.
- SP SCIENTIFIC
- SPECTROCELL, INC.
- ABBOTT LABORATORIES
- STEELGATE, INC.
- TRILLIUM THERAPEUTICS, INC.
- STEM CELLS, INC.
- STEMCELL TECHNOLOGIES, INC.
- LIFELINE® CELL TECHNOLOGY
- THERMO FISHER SCIENTIFIC, INC.
- CESCA THERAPEUTICS, INC.
- TRANS-HIT BIOMARKERS, INC.
- VAISALA, INC.
- VIACORD
- VITAL THERAPIES, INC.
- WHEATON SCIENCE PRODUCTS, INC.
- EUROPE
- PANASONIC BIOMEDICAL B.V
- EPISTEM LTD.
- AQIX
- B & C GROUP
- BBMRI
- LIFEGENE
- BIOBANK IRELAND TRUST
- BIOKRYO GMBH
- BIOREP SRL P.IVA
- BIOSTORAGE TECHNOLOGIES, INC.
- BOEHRINGER INGELHEIM, GMBH
- CELLS4LIFE, LTD.
- CRYO BIO SYSTEM
- CRYO-SAVE, AG
- DECODE GENETICS
- GE HEALTHCARE LIFE SCIENCES
- GENESISBPS
- HIGHRES BIOSOLUTIONS
- INDIVUMED
- LIFEGENE BIOBANK
- LIFELINES COHORT AND BIOBANK (LIFELINES)
- LINDE GAS CRYOSERVICES B.V.
- MODUL-BIO SAS
- MTS CRYOSTORES UK LTD
- NORAY BIOINFORMATICS S.L.U.
- RENEURON GROUP PLC
- SANOFI AVENTIS
- SOVENTEC GMBH
- STIRLING CRYOGENICS & REFRIGERATION BV
- TECAN
- TISSUE SOLUTIONS
- UK STEM CELL BANK
- ASIA-PACIFIC
- COLE PARMER INSTRUMENT, CO.
- CORDLIFE PTE., LTD.
- CRYOCORD SDN. BHD.
- CRYOLOGIC PTY. LTD.
- GENESEARCH
- OCIMUM BIOSOLUTIONS
- RELIANCE LIFE SCIENCES
- CHINA CORD BLOOD CORPORATION
- REST OF WORLD
- BABYCELL EGYPT
- GAMIDA CELL LTD
- IV. INDUSTRY COMPANY DATABASE
- V. APPENDIX
- A. RESEARCH FOCUS
- B. ABOUT AXIS RESEARCH MIND
- C. DISCLAIMER
- D. FEEDBACK
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.